| 2013 data (n = 166) | 2014 data (n = 170) | |
| People on I-neb (%) | 92 (55%) | 101 (59%) |
| People with ≥3 months of I-neb data (%) | 83 (50%) | 85 (50%) |
| Median % I-neb nebuliser adherence (IQR) | 40.5 (20.2–66.8) | 49.5 (23.1–77.8) |
| Median age in years (IQR) | 25 (19–31) | 26 (20–32) |
| Female (%) | 75 (45%) | 79 (46%) |
| Pancreatic insufficiency (%) | 138 (83%) | 136 (80%) |
| CF related diabetes (%) | 38 (23%) | 41 (24%) |
| Median % predicted FEV1 (IQR) | 79 (56–95) | 79 (56–93) |
| BMI (IQR) | 22.0 (19.7–24.6) | 22.7 (19.8–24.9) |
| Median IV days (IQR) | 14 (0–41) | 14 (0–28) |
| Total IV days | 3970 | 3313 |